FirstRanker Logo

FirstRanker.com - FirstRanker's Choice is a hub of Question Papers & Study Materials for B-Tech, B.E, M-Tech, MCA, M.Sc, MBBS, BDS, MBA, B.Sc, Degree, B.Sc Nursing, B-Pharmacy, D-Pharmacy, MD, Medical, Dental, Engineering students. All services of FirstRanker.com are FREE

📱

Get the MBBS Question Bank Android App

Access previous years' papers, solved question papers, notes, and more on the go!

Install From Play Store

Download OU Pharm D Question Paper 5th Sem 2018 1125 Clinical Research

Download OU (Osmania University) Pharm D (Doctor of Pharmacy) V Sem (5th Semester) 2018 1125 Clinical Research Previous Question Paper

This post was last modified on 04 March 2020

OU Pharm D Question Papers Last 10 Years 2010-2020 || Osmania University


FirstRanker.com

Code No. 1125

FACULTY OF PHARMACY

--- Content provided by​ FirstRanker.com ---

Pharm. D (6 YDC) V-Year (Instant) Examination, March 2018

Subject : Clinical Research

Time : 3 Hrs Max. Marks: 70

Note: Answer all questions from Part — A, answer any five questions from Part-B.

PART - A (10 x 2 = 20 Marks)

--- Content provided by⁠ FirstRanker.com ---

  1. What is Drug discovery? What are the steps involved in the process?
  2. What is IND “clinical hold”? Explain the basis for clinical hold.
  3. What is ANDA? Write note on its submission.
  4. What is PMS and PSUR?
  5. Write briefly the roles and responsibilities of CRC as per ICH GCP.
  6. --- Content provided by FirstRanker.com ---

  7. Write note on registration of clinical trials.
  8. Enumerate the essential documents in clinical trials.
  9. Write briefly about query management in CDM.
  10. What is Patient information sheet?
  11. What is blinding in clinical trials? What is its significance?
  12. --- Content provided by⁠ FirstRanker.com ---

PART - B (5 x 10 = 50 Marks)

  1. Explain the tools used in Lead identification and optimization.
  2. Explain toxicity studies carried out in preclinical drug development.
  3. Explain the objective, design and conduct of phase 1 clinical trial studies with schedule Y requirements.
  4. Explain NDA review process with contents and format requirements.
  5. --- Content provided by⁠ FirstRanker.com ---

  6. Explain the IEC Review procedure of a research proposal.
  7. Explain in detail the regulatory environment in USA.
  8. (a) Explain Data Entry methods.
    (b) Write about clinical trials database lock.
  9. Explain the role and responsibilities of sponsor in clinical trials as per ICH GCP.
  10. --- Content provided by‌ FirstRanker.com ---



This download link is referred from the post: OU Pharm D Question Papers Last 10 Years 2010-2020 || Osmania University

--- Content provided by​ FirstRanker.com ---